NoBoddy1 - FACEIT level 10, 2,337 ELO

Russia
On FACEIT since 2019 155 matches tracked 49 matches in 30 days
ELO ▼ 230
2,337
30-day peak: 2,567
Rank EU
#89,000
Russia #23,421 in Russia
Last updated:

NoBoddy1 at a glance

Level 10 2,337 ELO best map Mirage (53%)
2,250-2,499 ELO

Last 20 matches compared with 2,997 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 41%
1.01
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.37 ConsistencyShare of matches with a rating of 0.90 or higher. 60%
K/R
0.73
better than 44% of players
2,250-2,499 ELO avg: 0.74
Last 12 months
ADR
78.7
better than 39% of players
2,250-2,499 ELO avg: 80.8
Last 12 months
Win rate
35%
better than 6% of players
2,250-2,499 ELO avg: 50%
Last 12 months

Facts

230 ELO Next goal ELO to the peak (2,567)
2 W · 1 L Best day +27 ELO · Sep 12, 2026
4 W · 3 L Overtime in overtime
Mirage Favorite map 58 of 155 matches
Mirage 53% Map pool tip weakest: Ancient 25%
1 knife kill Rare kills last 90 days
0:00-3:00 Playing times most active
On Fridays Best time 61% win rate vs. 46%
FormMapsTiming

230 ELO away from the recorded peak (2,567). 2:1 on Sep 12, 2026 (+27 ELO, last 90 days). 7 matches in overtime, 4 of them won (last 90 days). Most played: Mirage (58 of 155 matches). Strongest map: Mirage (53% win rate, 58 matches). Weakest: Ancient (25%, 12 matches). 1 knife kill (last 90 days). Plays most between 0:00 and 3:00 (based on 155 matches). Best results on Fridays: 61% win rate vs. 46% overall (23 matches).

About NoBoddy1

NoBoddy1 plays CS2 on FACEIT level 10 with 2,337 ELO. The stats cover 155 matches. NoBoddy1 plays Mirage the most and wins it the most: 53% win rate in 58 matches. Biggest strength: Headshot rate at 57%, better than 87% of level 10 · 2,250-2,499 ELO players. Last 20 matches: 7 wins, 13 losses, -22 ELO. NoBoddy1 does best on Fridays: 61% win rate in 23 matches.